Skip to content

Research at St Andrews

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

Research output: Contribution to journalArticle

Author(s)

David C. Wedge, Gunes Gundem, Thomas Mitchell, Dan J. Woodstock, Inigo Martincorena, Mohammed Ghori, Jorge Zamora, Adam Butler, Hayley Whitaker, Zsofia Kote-Jarai, Lumil B. Alexandrov, Peter Van Loo, Charlie E. Massie, Stefan Dentro, Anne Y. Warren, Clare Verrill, Dan M. Berney, Nening Dennis, Sue Merson, Steve Hawkins & 68 others William Howat, Yong-Jie Lu, Adam Lambert, Jonathan Kay, Barbara Kremeyer, Katalin Karaszi, Niedzica Camacho, Hayley Luxton, Luke Marsden, Sandra Edwards, Lucy Matthews, Valeria Bo, Daniel Leongamornlert, Stuart McLaren, Anthony Ng, Yongwei Yu, Hongwei Zhang, Tokhir Dadaev, Sarah Thomas, Douglas F. Easton, Mahbubl Ahmed, Elizabeth Bancroft, Cyril Fisher, Naomi Livni, David Nicol, Simon Tavaré, Pelvender Gill, Christopher Greenman, Vincent Khoo, Nicholas Van As, Pardeep Kumar, Christopher Ogden, Declan Cahill, Alan Thompson, Erik Mayer, Edward Rowe, Tim Dudderidge, Vincent Gnanapragasam, Nimish C. Shah, Keiran Raine, David Jones, Andrew Menzies, Lucy Stebbings, Jon Teague, Steven Hazell, Cathy Corbishley, CamCaP Study Group, Johann de Bono, Gerhardt Attard, William Isaacs, Tapio Visakorpi, Michael Fraser, Paul C. Boutros, Robert G. Bristow, Paul Workman, Chris Sander, The TCGA Consortium, Freddie C. Hamdy, Andrew Futreal, Ultan McDermott, Bissan Al-Lazikani, Andy Lynch, G. Steven Bova, Christopher S. Foster, Daniel S. Brewer, David E. Neal, Colin S. Cooper, Rosalind A. Eeles

School/Research organisations

Abstract

Prostate cancer represents a substantial clinical challenge because it is difficult to predict outcome and advanced disease is often fatal. We sequenced the whole genomes of 112 primary and metastatic prostate cancer samples. From joint analysis of these cancers with those from previous studies (930 cancers in total), we found evidence for 22 previously unidentified putative driver genes harboring coding mutations, as well as evidence for NEAT1 and FOXA1 acting as drivers through noncoding mutations. Through the temporal dissection of aberrations, we identified driver mutations specifically associated with steps in the progression of prostate cancer, establishing, for example, loss of CHD1 and BRCA2 as early events in cancer development of ETS fusion-negative cancers. Computational chemogenomic (canSAR) analysis of prostate cancer mutations identified 11 targets of approved drugs, 7 targets of investigational drugs, and 62 targets of compounds that may be active and should be considered candidates for future clinical trials.
Close

Details

Original languageEnglish
Pages (from-to)682-692
Number of pages16
JournalNature Genetics
Volume50
DOIs
Publication statusPublished - 16 Apr 2018

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Multicentre validation of the CamGFR model for estimated glomerular filtration rate

    Williams, E. H., Connell, C. M., Weaver, J. M. J., Beh, I., Potts, H., Whitley, C. T., Bird, N., Al-Sayed, T., Fehr, M., Cathomas, R., Bertelli, G., Quinton, A., Lewis, P., Shamash, J., Wilson, P., Dooley, M., Poole, S., Mark, P. B., Bookman, M., Earl, H. & 4 others, Jodrell, D., Tavaré, S., Lynch, A. & Janowitz, T., 19 Sep 2019, In : JNCI Cancer Spectrum.

    Research output: Contribution to journalArticle

  2. Deciphering the genomic, epigenomic and transcriptomic landscapes of pre-invasive lung cancer lesions

    Texeira, V. H., Pipinikas, C. P., Pennycuick, A., Lee-Six, H., Chandrasekharan, D., Beane, J., Morris, T. J., Karpathakis, A., Feber, A., Breeze, C. E., Ntolios, P., Hynds, R. E., Falzon, M., Capitanio, A., Carroll, B., Durrenberger, P. F., Hardavella, G., Brown, J. M., Lynch, A. G., Farmery, H. & 12 others, Paul, D. S., Chambers, R. C., McGranahan, N., Navani, N., Thakrar, R. M., Swanton, C., Beck, S., George, P. J., Spira, A., Campbell, P. J., Thirwell, C. & Janes, S. M., Mar 2019, In : Nature Medicine. 25, p. 517-525 9 p.

    Research output: Contribution to journalArticle

  3. DESNT: a poor prognosis category of human prostate cancer

    Luca, B-A., Brewer, D. S., Edwards, D. R., Edwards, S., Whitaker, H. C., Merson, S., Dennis, N., Cooper, R. A., Hazell, S., Warren, A. Y., Eeles, R., Lynch, A. G., Ross-Adams, H., Lamb, A. D., Neal, D. E., Sethia, K., Mills, R. D., Ball, R. Y., Curley, H., Clark, J. & 2 others, Moulton, V. & Cooper, C. S., Dec 2018, In : European Urology Focus. 4, 6, p. 842-850 9 p.

    Research output: Contribution to journalArticle

  4. Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal

    Mitchell, T. J., Turajlic, S., Rowan, A., Nicol, D., Farmery, J. H. R., O’Brien, T., Martincorena, I., Tarpey, P., Angelopoulos, N., Yates, L. R., Butler, A. P., Raine, K., Stewart, G. D., Challacombe, B., Fernando, A., Lopez, J. I., Hazell, S., Chandra, A., Chowdhury, S., Rudman, S. & 27 others, Soultati, A., Stamp, G., Fotiadis, N., Pickering, L., Au, L., Spain, L., Lynch, J., Stares, M., Teague, J., Maura, F., Wedge, D. C., Horswell, S., Chambers, T., Litchfield, K., Xu, H., Stewart, A., Elaidi, R., Oudard, S., McGranahan, N., Csabai, I., Gore, M., Futreal, P. A., Larkin, J., Lynch, A. G., Szallasi, Z., Swanton, C. & Campbell, P. J., 19 Apr 2018, In : Cell. 173, 3, p. 611-623 13 p., e17.

    Research output: Contribution to journalArticle

Related by journal

  1. Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics

    Davies, M. R., McIntyre, L., Mutreja, A., Lacey, J. A., Lees, J. A., Towers, R. J., Duchêne, S., Smeesters, P. R., Frost, H. R., Price, D. J., Holden, M. T. G., David, S., Giffard, P. M., Worthing, K. A., Seale, A. C., Berkley, J. A., Harris, S. R., Rivera-Hernandez, T., Berking, O., Cork, A. J. & 18 others, Torres, R. S. L. A., Lithgow, T., Strugnell, R. A., Bergmann, R., Nitsche-Schmitz, P., Chhatwal, G. S., Bentley, S. D., Fraser, J. D., Moreland, N. J., Carapetis, J. R., Steer, A. C., Parkhill, J., Saul, A., Williamson, D. A., Currie, B. J., Tong, S. Y. C., Dougan, G. & Walker, M. J., Jun 2019, In : Nature Genetics. 51, 6, p. 1035-1043

    Research output: Contribution to journalArticle

  2. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance

    Secrier, M., Li, X., de Silva, N., Eldridge, M. D., Contino, G., Bornschein, J., MacRae, S., Grehan, N., O'Donovan, M., Miremadi, A., Yang, T-P., Bower, L., Chettouh, H., Crawte, J., Galeano-Dalmau, N., Grabowska, A., Saunders, J., Underwood, T., Waddell, N., Barbour, A. P. & 7 others, Nutzinger, B., Achilleos, A., Edwards, P. A. W., Lynch, A. G., Tavaré, S., Fitzgerald, R. C. & Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, 5 Sep 2016, In : Nature Genetics. 48, 10, p. 1131-1141 11 p.

    Research output: Contribution to journalArticle

  3. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

    Cooper, C. S., Eeles, R., Wedge, D. C., Van Loo, P., Gundem, G., Alexandrov, L. B., Kremeyer, B., Butler, A., Lynch, A. G., Camacho, N., Massie, C. E., Kay, J., Luxton, H. J., Edwards, S., Kote-Jarai, Z., Dennis, N., Merson, S., Leongamornlert, D., Zamora, J., Corbishley, C. & 51 others, Thomas, S., Nik-Zainal, S., O'Meara, S., Matthews, L., Clark, J., Hurst, R., Mithen, R., Bristow, R. G., Boutros, P. C., Fraser, M., Cooke, S., Raine, K., Jones, D., Menzies, A., Stebbings, L., Hinton, J., Teague, J., McLaren, S., Mudie, L., Hardy, C., Anderson, E., Joseph, O., Goody, V., Robinson, B., Maddison, M., Gamble, S., Greenman, C., Berney, D., Hazell, S., Livni, N., Fisher, C., Ogden, C., Kumar, P., Thompson, A., Woodhouse, C., Nicol, D., Mayer, E., Dudderidge, T., Shah, N. C., Gnanapragasam, V., Voet, T., Campbell, P., Futreal, A., Easton, D., Warren, A. Y., Foster, C. S., Stratton, M. R., Whitaker, H. C., McDermott, U., Brewer, D. S. & Neal, D. E., 28 Apr 2015, In : Nature Genetics. 47, 4, p. 367-372 6 p.

    Research output: Contribution to journalArticle

  4. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma

    Ross-Innes, C. S., Becq, J., Warren, A., Cheetham, R. K., Northen, H., O'Donovan, M., Malhotra, S., Di Pietro, M., Ivakhno, S., He, M., Weaver, J. M. J., Lynch, A. G., Kingsbury, Z., Ross, M., Humphray, S., Bentley, D., Fitzgerald, R. C., Hayes, S. J., Ang, Y., Welch, I. & 85 others, Preston, S., Oakes, S., Save, V., Skipworth, R., Tucker, O., Davies, J., Crichton, C., Schusterreiter, C., Underwood, T., Noble, F., Stacey, B., Kelly, J., Byrne, J., Haydon, A., Sharland, D., Owsley, J., Barr, H., Lagergren, J., Gossage, J., Davies, A., Mason, R., Chang, F., Zylstra, J., Sanders, G., Wheatley, T., Berrisford, R., Bracey, T., Harden, C., Bunting, D., Roques, T., Nobes, J., Loo, S., Lewis, M., Cheong, E., Priest, O., Parsons, S. L., Soomro, I., Kaye, P., Saunders, J., Pang, V., Welch, N., Catton, J. A., Duffy, J. P., Ragunath, K., Lovat, L., Haidry, R., Miah, H., Kerr, S., Eneh, V., Butawan, R., Lewis, M., Cheong, E., Kumar, B., Igali, L., Walton, S., Dann, A., Safranek, P., Hindmarsh, A., Sudjendran, V., Scott, M., Cluroe, A., Miremadi, A., Mahler-Araujo, B., Nutzinger, B., Peters, C., Abdullahi, Z., Crawte, J., MacRae, S., Noorani, A., Elliott, R. F., Bower, L., Edwards, P., Tavare, S., Eldridge, M., Bornschein, J., Secrier, M., Yang, T. P., O'Neill, J. R., Adamczuk, K., Lao-Sirieix, P., Grehan, N., Smith, L., Lishman, S., Beardsmore, D. & Dawson, S., 27 Aug 2015, In : Nature Genetics. 47, 9, p. 1038-1046 9 p.

    Research output: Contribution to journalArticle

ID: 252804614

Top